Blueprint Medicines Corp Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Blueprint Medicines Corp quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Blueprint Medicines Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $4.55M, a 3.2% increase year-over-year.
  • Blueprint Medicines Corp annual Operating Lease, Payments for 2023 was $17.7M, a 11.6% increase from 2022.
  • Blueprint Medicines Corp annual Operating Lease, Payments for 2022 was $15.9M, a 6.68% increase from 2021.
  • Blueprint Medicines Corp annual Operating Lease, Payments for 2021 was $14.9M, a 3.13% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.55M +$141K +3.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $4.41M +$523K +13.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $3.88M +$186K +5.03% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $3.7M +$115K +3.21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 $3.62M +$131K +3.76% Jul 1, 2020 Sep 30, 2020 10-Q 2020-10-29
Q1 2020 $13.2M $3.58M +$960K +36.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $12.2M $3.52M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-17
Q3 2019 $3.49M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $2.62M Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $2.62M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.